Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on July 2, 2026

an hour ago

Top 10 China Orthopedic Trauma Implant Manufacturers for the Turkish Market

Indeterminate EIN Presswire

4 hours ago

World-Renowned Spiritual Master Draws More Than 900 to Chicagoland Talk Broadcast to Audiences Across Three Continents

Indeterminate EIN Presswire

24 minutes ago

Treos Bio Presents New Translational Data Showing PolyPEPI1018 Plus Anti-PD-L1 Immunotherapy Remodels the Tumor Immune Microenvironment in MSS Colorectal Cancer

Indeterminate GlobeNewswire

24 minutes ago

The Ensign Group Purchases Real Estate and Operations in Texas

Indeterminate GlobeNewswire

2 hours ago

HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification

Indeterminate GlobeNewswire

2 hours ago

Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference

Indeterminate GlobeNewswire

2 hours ago

Anaveon Appoints Laetitia Pouzol as Chief Scientific Officer

Indeterminate GlobeNewswire

3 hours ago

Xeltis exceeds 50% enrollment in US Pivotal trial for aXess™, its vascular access device for hemodialysis

Indeterminate GlobeNewswire

4 hours ago

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

Indeterminate GlobeNewswire

4 hours ago

Abivax annonce l’exercice intégral de l’option de souscription d’ADS supplémentaires des teneurs de livre associés, portant le produit brut de l’Offre à 920 M$ (807 M€)

Indeterminate GlobeNewswire

5 hours ago

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

Indeterminate GlobeNewswire

6 hours ago

Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering

Indeterminate GlobeNewswire

7 hours ago

Pep Club Launches Telehealth Platform Combining Prescription Therapy, Peptide Protocols, and At-Home Biomarker Testing

Indeterminate GlobeNewswire

9 hours ago

FDA Alignment to Advance ProstACT Global Phase 3 Trial

Indeterminate GlobeNewswire

9 hours ago

GNI Group Completes Acquisition of AYUMI Pharmaceutical

Indeterminate GlobeNewswire

10 hours ago

Junshi Biosciences Enters Licensing Collaboration with Fosun Wanbang on Roconkibart (IL-17A)

Indeterminate GlobeNewswire